Other

Abbott Products Gmbh

Abbvie Pharmaceuticals Gmbh

Abbott Laboratories Corporation

Claus-Juergen Koelln

George Shlieout

Frithjof Sczesny

Jens Onken

Andreas Koerner

Martin Frink

Guido Ruesing

Heinz Blume

Michael Rust

A process for manufacturing and using pancreatin micropellet cores and pancreatin micropellets which are substantially free of synthetic oils. In one embodiment, a pharmaceutical composition is provided comprising a pancreatin micropellet with the enteric coating being designed to deliver pancreatin to the upper portion of the intestine of a mammal for release.

Process for the manufacture and use of pancreatin micropellet cores

A process for the manufacture and use of pancreatin in which the concentration of one or more biological contaminants is reduced, such as viruses and/or bacteria, through heating the pancreatin at a temperature of at least 85&#xb0; C. for a period of less than about 48 hours.

Processes for the manufacture and use of pancreatin

An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.

Delayed release pancreatin compositions

Growing community of inventors

Neustadt, Germany

Claus-Juergen Koelln